Sodium tetradecyl sulfate
Sotradecol (sodium tetradecyl sulfate) is a small molecule pharmaceutical. Sodium tetradecyl sulfate was first approved as Sotradecol on 1982-01-01. It is used to treat esophageal and gastric varices and varicose veins in the USA.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Sodium tetradecyl sulfate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SOTRADECOL | A.H. Robins Company | N-005970 DISCN | 1982-01-01 | 2 products, RLD |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
sodium tetradecyl sulfate | ANDA | 2023-01-10 |
sotradecol | ANDA | 2021-08-17 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
esophageal and gastric varices | EFO_0009545 | D004932 | I85 |
varicose veins | HP_0002619 | D014648 | I83.90 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
8 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Varicose veins | D014648 | HP_0002619 | I83.90 | — | — | — | 1 | 1 | 2 |
Venous insufficiency | D014689 | — | 1 | — | 1 | — | 2 |
Indications Phases 3
No data
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pain | D010146 | EFO_0003843 | R52 | 1 | — | — | — | — | 1 |
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | SODIUM TETRADECYL SULFATE |
INN | sodium tetradecyl sulfate |
Description | Sodium tetradecyl sulfate is an organic sodium salt having tetradecyl sulfate as the counterion. Used in the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves. It has a role as a detergent and a sclerotherapy agent. It contains a tetradecyl sulfate. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)[O-].[Na+] |
Identifiers
PDB | — |
CAS-ID | 139-88-8 |
RxCUI | — |
ChEMBL ID | CHEMBL1200354 |
ChEBI ID | 75273 |
PubChem CID | 23665772 |
DrugBank | DB00464 |
UNII ID | Q1SUG5KBD6 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 2,464 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
112 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more